Health-Related Quality-of-Life and Quality-Days Incrementally Gained in Symptomatic Nonerosive GERD Patients Treated with Lansoprazole or Ranitidine

Authors:

Abstract
Eight-hundred forty-nine patients with symptomatic nonerosive GERD from two clinical trials of lansoprazole 15 mg daily (LAN 15) and lansoprazole 30 mg daily (LAN 30) vs ranitidine 150 mg twice a day...

This publication has 21 references indexed in Scilit: